The efficacy of immune checkpoint inhibitors in advanced EGFR-Mutated non-small cell lung cancer after resistance to EGFR-TKIs: Real-World evidence from a multicenter retrospective study

BACKGROUND: The efficacy of immune checkpoint inhibitors (ICIs) in pretreated EGFR-mutated non-small cell lung cancer (NSCLC) patients is controversial. We conducted this multicenter retrospective study to examine the efficacy of ICIs in a real world setting. PATIENTS AND METHODS: We collected 116 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jia, Huang, Di, Wang, Yanrong, Li, Donghui, Yang, Xuejiao, Fu, Yan, Du, Nan, Zhao, Yan, Li, Xiaosong, Ma, Junxun, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504865/
https://www.ncbi.nlm.nih.gov/pubmed/36159795
http://dx.doi.org/10.3389/fimmu.2022.975246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504865/
https://www.ncbi.nlm.nih.gov/pubmed/36159795
http://dx.doi.org/10.3389/fimmu.2022.975246

Ejemplares similares